Neuren Pharmaceuticals Limited (ASX:NEU)

Neuren Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,488	1,588	3,178	1,001	475	147
Market Cap Growth	42.60%	-50.04%	217.33%	110.87%	222.46%	-40.72%
Enterprise Value	2,188	1,374	3,092	970	457	138
Last Close Price	19.70	12.50	24.97	7.95	3.77	1.28
PE Ratio	17.16	11.18	20.23	5442.54	-	-
Forward PE	71.30	19.45	32.20	19.55	-	-
PS Ratio	11.37	7.32	13.70	64.96	148.54	205.40
PB Ratio	7.70	4.36	15.49	24.08	12.10	6.09
P/TBV Ratio	7.70	4.36	15.49	24.08	12.10	6.09
P/FCF Ratio	18.09	-	17.19	279.73	-	-
P/OCF Ratio	18.08	-	17.18	278.25	-	-
EV/Sales Ratio	10.00	6.34	13.33	62.94	142.84	192.61
EV/EBITDA Ratio	11.89	7.67	15.52	-	-	-
EV/EBIT Ratio	11.89	7.67	15.52	-	-	-
EV/FCF Ratio	15.91	-	16.73	271.04	-	-
Asset Turnover	0.78	0.66	1.59	0.37	0.10	0.04
Quick Ratio	40.42	8.69	5.68	24.59	47.58	33.13
Current Ratio	40.42	8.73	5.78	25.77	49.87	33.13
Return on Equity (ROE)	54.96%	49.92%	127.30%	0.46%	-24.57%	-48.32%
Return on Assets (ROA)	41.13%	34.05%	85.52%	-1.10%	-15.83%	-27.98%
Return on Capital (ROIC)	42.42%	39.35%	100.92%	-1.13%	-16.22%	-28.94%
Return on Capital Employed (ROCE)	56.90%	49.20%	97.10%	-	-	-
Earnings Yield	5.99%	8.95%	4.94%	0.02%	-1.64%	-6.24%
FCF Yield	5.53%	-0.71%	5.82%	0.36%	-2.10%	-5.49%
Buyback Yield / Dilution	0.98%	-0.01%	-1.44%	-8.76%	-10.71%	-6.88%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.